ES2134740A1 - Composicin analgesica, sin efectos secundarios. - Google Patents

Composicin analgesica, sin efectos secundarios.

Info

Publication number
ES2134740A1
ES2134740A1 ES09702563A ES9702563A ES2134740A1 ES 2134740 A1 ES2134740 A1 ES 2134740A1 ES 09702563 A ES09702563 A ES 09702563A ES 9702563 A ES9702563 A ES 9702563A ES 2134740 A1 ES2134740 A1 ES 2134740A1
Authority
ES
Spain
Prior art keywords
side effects
analgesic composition
acid
composition
sulphate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09702563A
Other languages
English (en)
Other versions
ES2134740B1 (es
Inventor
Tudela Bernardo Hernandez
Amigo Vicente Villar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES9702563A priority Critical patent/ES2134740B1/es
Publication of ES2134740A1 publication Critical patent/ES2134740A1/es
Application granted granted Critical
Publication of ES2134740B1 publication Critical patent/ES2134740B1/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

El objeto de la invención es una composición analgésica, sin efectos secundarios, cuya composición cualitativa y cuantitativa, expresada esta última en porcentaje de participación de cada componente en el peso del producto contenido en una cápsula de gelatina blanda, está comprendido entre los siguientes umbrales de tolerancia: - N-acetil glucosamina 10/30 % - Sulfato de glucosamina 10/30 % - Sulfato de condroitina 5/10 % - Acido eicosapentanoico (EPA) 15/20 % - Acido dicosahexanoico (DHA) 10/15 % - Acido gammalinoleico (GLA) 10/15 % - Vitamina E (DL-alfa-tocoferol) 0,4/0,5 % - Palmitato de ascorbilo 0,2/0,3 % - Aspartato de manganeso 0,03/0,05 %
ES9702563A 1997-12-10 1997-12-10 Composicin analgesica, sin efectos secundarios. Expired - Lifetime ES2134740B1 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES9702563A ES2134740B1 (es) 1997-12-10 1997-12-10 Composicin analgesica, sin efectos secundarios.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9702563A ES2134740B1 (es) 1997-12-10 1997-12-10 Composicin analgesica, sin efectos secundarios.

Publications (2)

Publication Number Publication Date
ES2134740A1 true ES2134740A1 (es) 1999-10-01
ES2134740B1 ES2134740B1 (es) 2000-05-01

Family

ID=8301451

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9702563A Expired - Lifetime ES2134740B1 (es) 1997-12-10 1997-12-10 Composicin analgesica, sin efectos secundarios.

Country Status (1)

Country Link
ES (1) ES2134740B1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108567973B (zh) * 2017-10-17 2021-03-19 中国科学院深圳先进技术研究院 一种胎盘样硫酸软骨素a免疫组合物及应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997021434A1 (en) * 1995-12-11 1997-06-19 Inholtra, Inc. Dietary regimen of nutritional supplements for relief of symptoms of arthritis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997021434A1 (en) * 1995-12-11 1997-06-19 Inholtra, Inc. Dietary regimen of nutritional supplements for relief of symptoms of arthritis

Also Published As

Publication number Publication date
ES2134740B1 (es) 2000-05-01

Similar Documents

Publication Publication Date Title
ZA935976B (en) Fatty acid treatment.
AU586892B2 (en) Pharmaceutical and dietary composition
BG102425A (en) (methylsulphonyl)phenyl-2-(5h)-furanons as cyclooxygenase-2-inhibitors
BR9809171A (pt) Processo de tratamento de uma matéria-prima láctica, contendo gmp
PT702954E (pt) Suplemento dietetico de calcio
IL146438A0 (en) Process and product for enhancing immune response in companion animal using a combination of antioxidants
DE3164507D1 (en) Pharmaceutical and dietary compositions
EP0625312A4 (en) FOOD COMPOSITION.
AU2001268145A1 (en) Compositions for treating eye discomfort containing herbals and/or nutritional supplements and/or minerals and/or vitamins
AU6843000A (en) High lipid diet
BR9801181A (pt) Alimento fortificado com cálcio.
HK1024869A1 (en) Food composition.
PL330865A1 (en) Agents containing lectins and their application
ATE214613T1 (de) Zusammensetzungen, die einen guggul-extrakt mit phosphatsalzen enthalten
EP0790060A4 (en) LIPIDIC AGENT FOR IMPROVING METABOLISM
FR2656772B1 (fr) Procede d'incorporation dans des pellets de principes actifs proteges contre la degradation dans la panse des ruminants.
ES2134740A1 (es) Composicin analgesica, sin efectos secundarios.
AU7986798A (en) Method of enhancing magnesium absorption and prevention of atherosclerosis
AU2001275144A1 (en) Compositions for enhancing therapeutic effects containing herbals and/or nutritional supplements and/or minerals and/or vitamins
UA43399C2 (uk) Композиція для гігієни, профілактики і лікування захворювань порожнини рота
EP1158977A4 (en) METHOD AND COMPOSITION RELATING TO THE ADMINISTRATION OF A CYCLO-OXYGENASE-2 INHIBITOR
GB9718413D0 (en) Compositions
AU3108289A (en) Compositions comprising 24,25-dihydroxy-vitamin D3 and calcium for the treatment of osteoporosis in humans
AU6473894A (en) A heterogeneous composition for feeding animals
AU8452791A (en) 1-phenyl-3-aryl-2-propyne-1-ones

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19991001

Kind code of ref document: A1

Effective date: 19991001